Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Ibrahim Turkoz"'
Autor:
Ibrahim Turkoz, Joshua Wong, Benjamin Chee, Uzma Siddiqui, R. Karl Knight, Ute Richarz, Christoph U. Correll
Publikováno v:
Therapeutic Advances in Psychopharmacology, Vol 13 (2023)
Background: The paliperidone palmitate 6-month (PP6M) long-acting injectable formulation is currently the longest dosing interval available for schizophrenia treatment. Objective: To compare treatment outcomes between a real-world external comparator
Externí odkaz:
https://doaj.org/article/50a28e7524cd4cc5bd7cf06f095c8f36
Autor:
Alexander Keenan, Yvonne Kayiteshonga, Larry Alphs, Ibrahim Turkoz, Virginia Smith-Swintosky, Emily Abraham, Alain Schotte, Eileen Hooker, Jean Damascene Iyamuremye, Rutakayile Bizoza, Branislav Mancevski
Publikováno v:
BMJ Open, Vol 13, Iss 4 (2023)
Objective To evaluate the feasibility of conducting a large clinical trial within the Rwandan mental healthcare system that would establish the safety, efficacy and benefit of paliperidone palmitate once-monthly (PP1M) and once-every-3-months (PP3M)
Externí odkaz:
https://doaj.org/article/ea1cdb21811f495eba1fdcec76dcc478
Autor:
David J. Williamson, Keith H. Nuechterlein, Todd Tishler, Joseph Ventura, Benjamin M. Ellingson, Ibrahim Turkoz, Richard S.E. Keefe, Larry Alphs
Publikováno v:
Schizophrenia Research: Cognition, Vol 30, Iss , Pp 100270- (2022)
Objective: Persons with schizophrenia exhibit greater neurocognitive test score dispersion. Here, we seek to characterize dispersion on the Neurocognitive Composite subtests of the Measurement of Treatment Research to Improve Cognition in Schizophren
Externí odkaz:
https://doaj.org/article/19df96c5526c40fd9d7ef4b01200ce4e
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol 2010, Iss Issue 1, Pp 667-679 (2010)
Carla M Canuso1, Ibrahim Turkoz2, Dong Jing Fu3, Cynthia A Bossie31External Innovation Neuroscience Therapeutic Area, 2Biostatistics, Johnson & Johnson Pharmaceutical Research and Development, LLC, Titusville, NJ, USA; 3CNS Medical Affairs, Ortho-McN
Externí odkaz:
https://doaj.org/article/adcc3cc9eec44cc5bcc3b18f4f62850a
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol 2008, Iss Issue 5, Pp 949-958 (2008)
Ibrahim Turkoz, Cynthia A Bossie, Bryan Dirks, Carla M CanusoOrtho-McNeil Janssen Scientific Affairs, LLC, Titusville, NJ, USAAbstract: Direct and indirect effects of the new psychotropic paliperidone extended-release (paliperidone ER) tablets on neg
Externí odkaz:
https://doaj.org/article/a85737ed2de249969bd1778a236c12c1
Autor:
David, Williamson, Ibrahim, Turkoz, Ewa, Wajs, Jaskaran B, Singh, Stephane, Borentain, Wayne C, Drevets
Publikováno v:
International Journal of Neuropsychopharmacology. 26:198-206
Background “Dissociation” comprises distinct phenomena, some of which are associated with esketamine treatment and some may overlap with positive symptoms of psychosis. Relationships between dissociation and psychotic symptoms assessed by clini
Autor:
Larry, Alphs, Pamela, Baker, Brianne, Brown, Dong-Jing, Fu, Ibrahim, Turkoz, Keith H, Nuechterlein
Publikováno v:
Schizophrenia Research. 248:58-63
A post hoc analysis of the Disease Recovery Evaluation and Modification (DREaM) study was conducted to evaluate time to first major treatment failure (ie, arrest/incarceration or psychiatric hospitalization) in participants with recent-onset schizoph
Autor:
Ibrahim, Turkoz, Oliver, Lopena, Giacomo, Salvadore, Gerard, Sanacora, Richard, Shelton, Dong-Jing, Fu
Publikováno v:
CNS Spectrums. :1-24
To assess the likelihood of attaining response/remission of depressive symptoms with esketamine nasal spray (ESK) plus standard of care (SoC) vs placebo nasal spray (PBO) plus SoC at 4 weeks in patients with major depressive disorder and active suici
Autor:
Alexander Keenan, Ludwig Kappos, Maria Ait-Tihyaty, Kavita Gandhi, Ibrahim Turkoz, Janice Wong, Tatiana Sidorenko, Fred Lublin
Publikováno v:
Monday, April 24.
Autor:
Maju Mathews, Vanina Popova, Ibrahim Turkoz, William V McCall, Frank Wiegand, David Williamson, Stephane Borentain
Publikováno v:
Neuropsychiatric Disease and Treatment
Stephane Borentain,1 David Williamson,2,3 Ibrahim Turkoz,4 Vanina Popova,5 William V McCall,3 Maju Mathews,1 Frank Wiegand1 1Department of Global Medical Affairs, Janssen Research & Development, LLC, Titusville, NJ, USA; 2CNS Scientific Affairs Liais